EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Significant Dissatisfaction with an Outdated System: A Survey on the Experience of Application for Off-Label Use of Anti-cancer Drugs by the Korean Society of Medical Oncology

Jae Lyun Lee, Dong-Hoe Koo, Young-Woong Won, Young Saing Kim, Hee Kyung Ahn, Seungtaek Lim

Cancer Research and Treatment · 2025

DOI: 10.4143/crt.2024.749 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Research and Treatment, 2025. Verfasst von Jae Lyun Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Off-Label Use, Antineoplastic Agents, Medical Oncology, Oncologists. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Ipsen Korea, GI Innovation, LG Chem.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study evaluates the experiences and satisfaction levels of Korean medical oncologists with the prior authorization system for the off-label use of anti-cancer drugs. Conducted by the Korean Society of Medical Oncology (KSMO), the survey aimed to identify challenges and areas for improvement in the current regulatory framework.Materials and Methods A cross-sectional web-based survey was carried out between May 4 and May 14, 2023, targeting 261 active KSMO medical oncologists. Invitations were sent via email, and the survey, comprising 19 questions, was hosted on Microsoft Forms. The questions covered personal characteristics, work environment, experiences with the pre-application process, and post-approval experiences.

Results

For the 261 invitations sent, 110 responses (42.1%) were received. Most respondents had over 10 years of experience and worked in tertiary hospitals. Although 93.6% were familiar with the pre-application system, 67.3% expressed moderate to high dissatisfaction. The key issues included complex applications, long approval period, stringent criteria, and inconsistent reviews. Additionally, 74.4% of respondents spent over 3 hours on first-time applications, with 68.3% experiencing rejections. Emotional responses to rejections were largely negative, with many feeling disregarded. Post-approval, patients of 96.8% of respondents faced financial burdens leading to treatment discontinuation. Most oncologists (86.0%) supported selective reimbursement if the disease was controlled for a certain period.

Conclusion

The survey highlights significant dissatisfaction with the current system, suggesting the need for streamlining the application process, easing approval criteria, and reconsidering the financial aspects of post-approval treatments to support patient care and oncologists’ decision-making autonomy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Off-Label UseAntineoplastic AgentsMedical OncologyOncologistsNeoplasmsHumansRepublic of KoreaCross-Sectional StudiesSurveys and QuestionnairesFemaleMaleMiddle AgedAdultSocieties, Medical

Stichwörter der Autor:innen

Health policyOff-label useOncologistsSurveys and questionnaires

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Division of Hematology-Oncology, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Division of Hematology and Oncology, Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
  • Division of Medical Oncology, Department of Internal Medicine, Gil Medical Center, Gachon University College of Medicine, Incheon, Korea.
  • Department of Hemato-Oncology, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.

Förderung

  • Ipsen Korea
  • GI Innovation
  • LG Chem
  • Oscotec
  • AstraZeneca
  • Bayer
  • Boehringer Ingelheim
  • Exelixis

Zitieren

APA

Lee, J. L., Koo, D. H., Won, Y. W., Kim, Y. S., Ahn, H. K., & Lim, S. (2025). Significant Dissatisfaction with an Outdated System: A Survey on the Experience of Application for Off-Label Use of Anti-cancer Drugs by the Korean Society of Medical Oncology. Cancer Research and Treatment. https://doi.org/10.4143/crt.2024.749

Vancouver

Lee JL, Koo DH, Won YW, Kim YS, Ahn HK, Lim S. Significant Dissatisfaction with an Outdated System: A Survey on the Experience of Application for Off-Label Use of Anti-cancer Drugs by the Korean Society of Medical Oncology. Cancer Research and Treatment. 2025. doi:10.4143/crt.2024.749

BibTeX
@article{Lee2025,
  author = {Lee, Jae Lyun and Koo, Dong-Hoe and Won, Young-Woong and Kim, Young Saing and Ahn, Hee Kyung and Lim, Seungtaek},
  title = {Significant Dissatisfaction with an Outdated System: A Survey on the Experience of Application for Off-Label Use of Anti-cancer Drugs by the Korean Society of Medical Oncology},
  journal = {Cancer Research and Treatment},
  year = {2025},
  doi = {10.4143/crt.2024.749}
}
Kostenlos starten →